Abstract

The presence of uterine leiomyoma may increase the incidence of complications such as premature delivery, miscarriage, abnormal fetal position and postpartum hemorrhage. Therefore, for these patients, the use of pituitrin needs to be particularly cautious. To study the effect of pituitrin on pregnancy outcomes of pregnant women with uterine leiomyoma of different sizes and sizes (uterine fibroids). A total of 193 single pregnancy patients with uterine fibroids admitted to the obstetrics department of the First Affiliated Hospital of Zhejiang Chinese Medicine University from January 2018 to July 2022 were selected, and their clinical data were retrospectively analyzed. According to the size of fibroids seen during pelvic color Doppler ultrasonography or intraoperation cesarean section during the third trimester of pregnancy, they were divided into 117 cases in the small fibroid group (<5 cm) and 76 cases in the large fibroid group (≥5 cm). Therefore, for the patients with pregnancy combined with uterine leiomyoma, the pregnancy outcome is affected by many factors. In addition to the use of pituitarin, they also include the age of the patient, the history of pregnancy, and the biological characteristics of the fibroids. When conducting clinical analysis, these factors need to be taken into account in order to reach a more accurate and comprehensive conclusion. Therefore, we need to pay attention to monitoring and preventing related complications during each pregnancy and delivery, so as to reduce the incidence of adverse outcomes, so as to provide a theoretical basis for obstetrical clinicians to manage pr egnancy complicated with uterine fibr oids in the perinatal period.